Avadel Pharmaceuticals plc
(NASDAQ: AVDL)

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

21.342

-0.013 (-0.06%)
Range 21.340 - 21.380   (0.19%)
Open 21.370
Previous Close 21.355
Bid Price 13.860
Bid Volume 10
Ask Price 13.900
Ask Volume 8
Volume 104,710
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis